tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market
PBYI
Puma Biotechnology
RESEARCH TOOLSreports

Puma Biotechnology (PBYI) Income Statement

670 Followers

Puma Biotechnology Income Statement

Last quarter (Q4 2025), Puma Biotechnology's total revenue was $75.50M, an increase of 27.80% from the same quarter last year. In Q4, Puma Biotechnology's net income was $13.40M. See Puma Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 228.37M$ 230.47M$ 235.64M$ 228.03M$ 253.16M
Gross Profit
$ 170.21M$ 166.06M$ 172.96M$ 172.94M$ 189.45M
Operating Expenses
$ 132.91M$ 135.10M$ 140.31M$ 149.22M$ 188.16M
Depreciation and Amortization
$ 10.94M$ 11.52M$ 11.52M$ 9.84M$ 11.30M
EBITDA
$ 53.34M$ 48.08M$ 47.52M$ 21.89M$ -4.69M
Operating Income
$ 37.30M$ 30.97M$ 32.64M$ 23.72M$ 1.29M
Other Income/Expenses
$ -1.52M$ -6.87M$ -9.97M$ -23.26M$ -30.09M
Pretax Income
$ 35.78M$ 24.10M$ 22.67M$ 457.00K$ -28.80M
Net Income
$ 31.11M$ 30.28M$ 21.59M$ 2.00K$ -29.13M
Per Share Metrics
Basic EPS
$ 0.62$ 0.62$ 0.46$ 0.02$ -0.72
Diluted EPS
$ 0.61$ 0.62$ 0.45$ 0.02$ -0.72
Weighted Average Shares Outstanding
 50.01M 48.65M 47.13M 44.67M 40.64M
Weighted Average Shares Outstanding (Diluted)
 50.65M 49.10M 47.55M 44.93M 40.64M
Currency in USD

Puma Biotechnology Earnings and Revenue History